Opioid-Induced Constipation Market 2015 - Size, Share, Demand, Growth & Opportunities

1
Top 10 Diabetes Care Technologies, Devices and
Therapeutics Markets - Growth, Global Share,
Industry Overview, Analysis, Trends Opportunities
and Forecast 2012 - 2020
Global Opioid-Induced Constipation Market
2015-2019 Growth, Global Share, Industry
Overview, Analysis, Trends Opportunities and
Forecast
2
Description
Report Overview
About Opioid-induced Constipation  Opioids are
administered to the patients with acute and
non-cancer chronic pain. They have several
adverse gastrointestinal effects, one of which is
opioid-induced constipation. The opioid
analgesics produce analgesia by the activation of
the mu receptors found in the CNS and PNS. These
drugs affect the motility, tone, and
contractility of the bowel functions, which
results in the delay in the transit of fecal
contents. The opioids also cause a reduction in
the secretion of digestive enzymes and also cause
partial gastroparesis. Some of the common
symptoms of opioid-induced constipation are hard
and dry stools, painful defecation, bloating,
distention and bulged abdomen, feeling lethargic,
and loss of appetite. Opioid-induced constipation
can be managed by changing lifestyle along with
the use of targeted therapies and other OTC and
off-label drugs.   The global opioid-induced
constipation market to grow at a CAGR of 30.18
over the period 2014-2019.   Read more details
at httphttp//www.bigmarketresearch.com/global-o
pioid-induced-constipation-2015-2019-market
3
Key Benefits
Summery
Covered in this Report   Global Opioid-induced
Constipation Market, report covers the present
scenario and the growth prospects of the global
opioid-induced constipation market for 2015-2019.
To calculate the market size, the report
considers revenue generated from sales of various
drugs used in the treatment of opioid-induced
constipation, which includes branded drugs,
off-label products, and OTC drugs.   On the
basis of the mechanism of action of drugs, the
market is grouped into the following
categories Peripherally Acting Mu-opioid
Receptor Antagonist Locally Acting Chloride
Channel Activator Others   Global
Opioid-induced Constipation Market 2015-2019, has
been prepared based on an in-depth market
analysis with inputs from industry experts. The
report covers the market landscape and its growth
prospects in the coming years. The report also
includes a discussion of the key vendors
operating in this market.  
4
Key Audiences
Key Regions Americas APAC EMEA  Key
Vendors AstraZeneca Takeda Pharmaceutical
Valeant Pharmaceuticals International  Other
Prominent Vendors Abbott Bayer Boehringer
Ingelheim C.B. Fleet Cosmo Pharmaceuticals
Daewoong Daiichi Sankyo GlaxoSmithKline
Ironwood Pharmaceuticals
5
Table Of Contents
Company Profile
Market Driver Unmet Medical Needs For a full,
detailed list, view our report   Market
Challenge Availability of OTC and Off-label
Drugs For a full, detailed list, view our
report   Market Trend Shift to Targeted
Therapy For a full, detailed list, view our
report Enquire about report http//www.bigmarket
research.com/report-enquiry/250762
6
Get Full Information At http//www.bigmarketrese
arch.com/global-opioid-induced-constipation-2015-2
019-market